Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,085 | 20 | 97.2% |
| Education | $31.50 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $288.56 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $230.33 | 3 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $185.76 | 2 | $0 (2018) |
| ITI, Inc. | $121.88 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $105.88 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $102.50 | 7 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $33.93 | 1 | $0 (2017) |
| Horizon Pharma plc | $16.81 | 1 | $0 (2017) |
| ZOLL Respicardia, Inc. | $15.74 | 1 | $0 (2022) |
| Smith+Nephew, Inc. | $14.61 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.88 | 1 | E.R. Squibb & Sons, L.L.C. ($105.88) |
| 2022 | $152.23 | 3 | ITI, Inc. ($121.88) |
| 2020 | $113.61 | 1 | Allergan, Inc. ($113.61) |
| 2019 | $230.33 | 3 | Janssen Pharmaceuticals, Inc ($230.33) |
| 2018 | $204.44 | 9 | Sunovion Pharmaceuticals Inc. ($102.50) |
| 2017 | $309.51 | 4 | Allergan Inc. ($143.45) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $105.88 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2022 | Smith+Nephew, Inc. | OASIS MICRO (Device) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Extra Cellular Matrix | ||||||
| 06/09/2022 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Respiratory | ||||||
| 01/29/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $115.27 | General |
| Category: Neuroscience | ||||||
| 05/01/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Neuroscience | ||||||
| 03/20/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $111.27 | General |
| Category: Neuroscience | ||||||
| 11/26/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: CNS | ||||||
| 10/29/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: CNS | ||||||
| 09/26/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: CNS | ||||||
| 09/19/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: CNS | ||||||
| 09/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: CNS | ||||||
| 07/23/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $70.44 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CNS | ||||||
| 04/12/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CNS | ||||||
| 10/12/2017 | Allergan Inc. | NAMENDA XR (Drug), NAMZARIC | Food and Beverage | In-kind items and services | $143.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $115.32 | General |
| Category: PSYCHIATRY | ||||||
| 07/06/2017 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: RAYOS | ||||||
| 03/30/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 77 | 130 | $30,776 | $8,551 |
| 2022 | 2 | 99 | 211 | $50,263 | $13,863 |
| 2021 | 3 | 119 | 235 | $57,333 | $16,250 |
| 2020 | 2 | 108 | 262 | $45,802 | $16,439 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 111 | $24,753 | $6,754 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $6,023 | $1,798 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 196 | $43,708 | $11,425 | 26.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 15 | 15 | $6,555 | $2,438 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 203 | $45,269 | $12,687 | 28.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 16 | 16 | $6,992 | $2,274 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $5,072 | $1,289 | 25.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 243 | $37,499 | $13,956 | 37.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 19 | $8,303 | $2,483 | 29.9% |
About Dr. Silvia Hafliger, MD
Dr. Silvia Hafliger, MD is a Psychiatry healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285619171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Silvia Hafliger, MD has received a total of $1,116 in payments from pharmaceutical and medical device companies, with $105.88 received in 2024. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,085).
As a Medicare-enrolled provider, Hafliger has provided services to 403 Medicare beneficiaries, totaling 838 services with total Medicare billing of $55,103. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Houston, TX
- Active Since 12/13/2005
- Last Updated 07/21/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1285619171
Products in Payments
- SPRAVATO (Drug) $226.54
- ABILIFY MAINTENA (Drug) $185.76
- VRAYLAR (Drug) $145.11
- NAMENDA XR (Drug) $143.45
- CAPLYTA (Drug) $121.88
- COBENFY (Drug) $105.88
- LATUDA (Drug) $102.50
- XIFAXAN (Drug) $33.93
- RAYOS (Drug) $16.81
- remede System (Device) $15.74
- OASIS MICRO (Device) $14.61
- INVEGA SUSTENNA (Drug) $3.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Houston
Dr. Lawrence Ginsberg, M.d, M.D
Psychiatry — Payments: $1.1M
Dr. Mazhar Khowaja
Psychiatry — Payments: $897,870
Barry Gritz, M.d, M.D
Psychiatry — Payments: $731,949
Dr. Frank Chen, Md Pa, MD PA
Psychiatry — Payments: $721,138
Dr. Aaron Peterson, Do, DO
Psychiatry — Payments: $549,804
Ayesha Rashid, M.d, M.D
Psychiatry — Payments: $445,948